{"CONCEPT_ID":[40171288],"CDM_TABLE_NAME":["DRUG_ERA"],"CONCEPT_NAME":["tocilizumab"],"NUM_PERSONS":[1],"PERCENT_PERSONS":["0.0006"],"RECORDS_PER_PERSON":[" 1.0"],"AGE_AT_FIRST_EXPOSURE":[{"CATEGORY":"FEMALE","MIN_VALUE":57,"P10_VALUE":57,"P25_VALUE":57,"MEDIAN_VALUE":57,"P75_VALUE":57,"P90_VALUE":57,"MAX_VALUE":57}],"PREVALENCE_BY_GENDER_AGE_YEAR":[{"TRELLIS_NAME":"50-59","SERIES_NAME":"FEMALE","X_CALENDAR_YEAR":2020,"Y_PREVALENCE_1000PP":8.3333}],"PREVALENCE_BY_MONTH":[{"X_CALENDAR_MONTH":202003,"Y_PREVALENCE_1000PP":0.646}],"LENGTH_OF_ERA":[{"CATEGORY":"Length of Era","MIN_VALUE":0,"P10_VALUE":0,"P25_VALUE":0,"MEDIAN_VALUE":0,"P75_VALUE":0,"P90_VALUE":0,"MAX_VALUE":0}]}
